炎症蛋白可能调解肠道微生物群和炎症性肠道疾病之间的因果关系:一种调解和多变量门德尔随机化研究
Yu-Liang Huang1,2, Jin-Min Zheng1, Zheng-Yi Shi1,2
1Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Medicine
|June 21, 2024
概括
这项研究揭示了关键的肠道细菌和与炎症性肠道疾病 (IBD) 相关的炎症性蛋白质,包括克罗恩病 (CD) 和性结肠炎 (UC). 特定的蛋白质调解这些肠道微生物组效应,为IBD提供新的治疗点.
科学领域:
- 微生物组研究的研究.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),涉及宿主基因,肠道微生物和免疫反应之间的复杂相互作用.
- 了解将特定肠道微生物种群与IBD病原体联系起来的因果途径对于开发向疗法至关重要.
研究的目的:
- 研究肠道微生物群,炎症蛋白和IBD (CD和UC) 之间的因果关系.
- 为了确定作为肠道微生物群-IBD轴中介的炎症蛋白质.
- 发现肠道微生物组中的潜在治疗点,用于IBD管理.
主要方法:
- 在来自MiBioGen (微生物组) 的大规模数据集上利用门德尔的随机化 (MR) 分析, Zhao等. (炎症蛋白) 和IIBDGC (IBD遗传学).
- 采用逆方差加权,MR-Egger和加权中位数方法来进行可靠的关联分析.
- 进行复制,元分析,调解器MR和多变量MR以确认发现并阐明调解途径.
主要成果:
- 确定了11种肠道微生物种群和17种具有CD和UC的炎症蛋白之间的显著因果关联.
- 揭示的调解作用:CD40L受体的DefluviitaleaceaeUCG-011在CD (8.3%),肝细胞生长因子的臭虫在CD (18%),和C-C动机化学素4的鲁米诺科克2在UC (4%).
结论:
- 确立了特定的肠道微生物群-炎症蛋白相互作用,有助于CD和UC的发展.
- 突出了涉及CD40L,肝细胞生长因子和C-C动机化学因子的潜在调解机制 4.
- 这些发现表明,针对IBD治疗的肠道微生物群和相关的炎症途径,可以提出新的治疗策略.
相关概念视频
Irritable Bowel Syndrome I: Introduction
268
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
268
Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease I: Ulcerative Colitis
161
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
161
Inflammatory Bowel Disease II: Crohn's Disease
213
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
213
Inflammatory Bowel Disease V: Surgical Management
139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
139


